Cargando…

Impact of Antipsychotic Guidelines on Laboratory Monitoring in Children with Neurodevelopmental Disorders

Objectives: The Canadian Alliance for Monitoring Effectiveness and Safety of Antipsychotics in Children (CAMESA) guidelines provide monitoring recommendations for children who are treated with second-generation antipsychotics (SGAs). The objective of this study was to determine the impact of the CAM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kara, Imaan, Penner, Melanie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc., publishers 2021
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891197/ https://www.ncbi.nlm.nih.gov/pubmed/33052712 http://dx.doi.org/10.1089/cap.2020.0096

Ejemplares similares

Adherence to antipsychotic laboratory monitoring guidelines in children and youth: a population-based study
por: Antoniou, Tony, et al.
Publicado: (2023)

Audit of physical health monitoring in children and adolescents receiving antipsychotics in neurodevelopmental clinics in Northumberland
por: Gnanavel, Sundar, et al.
Publicado: (2018)

Prevalence and Associated Factors of Emotional and Behavioural Difficulties during COVID-19 Pandemic in Children with Neurodevelopmental Disorders
por: Nonweiler, Jacqueline, et al.
Publicado: (2020)

Methodology for the early identification of neurodevelopmental disorders in the primary and preschool children in rural India by applying intervention module developed for teachers
por: Esakki, Bobby, et al.
Publicado: (2023)

Weight Monitoring and Antipsychotics: Are We Compliant With NICE Guidelines?
por: Mitchell, Byrone, et al.
Publicado: (2023)

Neurodevelopmental disorders and somatic diagnoses in a national cohort of children born before 24 weeks of gestation
por: Morsing, Eva, et al.
Publicado: (2022)

Exploring parental experiences of virtual paediatric neurodevelopmental consultations
por: Finnegan, Rebecca, et al.
Publicado: (2021)

Allelic and phenotypic heterogeneity in Junctophillin-3 related neurodevelopmental and movement disorders
por: Bourinaris, Thomas, et al.
Publicado: (2021)

Cannabidiol and Neurodevelopmental Disorders in Children
por: Kwan Cheung, Keith A., et al.
Publicado: (2021)

Biallelic PRMT7 pathogenic variants are associated with a recognizable syndromic neurodevelopmental disorder with short stature, obesity, and craniofacial and digital abnormalities
por: Cali, Elisa, et al.
Publicado: (2023)

2D:4D Ratio in Neurodevelopmental Disorders: A Twin Study
por: Myers, Lynnea, et al.
Publicado: (2018)

Biallelic loss‐of‐function variants in RBL2 in siblings with a neurodevelopmental disorder
por: Brunet, Theresa, et al.
Publicado: (2020)

Guideline Adherence of Monitoring Antipsychotic Use for Nonpsychotic Indications in Children and Adolescents: A Patient Record Review
por: Dinnissen, Mariken, et al.
Publicado: (2021)

Enhanced detection of gaze toward an object: Sociocognitive influences on visual search
por: Ramamoorthy, Nayantara, et al.
Publicado: (2020)

Editorial: Understanding the impact of AI and technology on the assessment, monitoring, and treatment of neurodevelopmental disorders
por: Pacella, Daniela, et al.
Publicado: (2023)

Seborrheic Dermatitis: A Case of an Atypical Side Effect of Atypical Antipsychotics
por: Bishay, Ramy, et al.
Publicado: (2023)

Effectiveness and Tolerability of Switching to Aripiprazole Once Monthly from Antipsychotic Polypharmacy and/or Other Long Acting Injectable Antipsychotics for Patients with Schizophrenia in Routine Practice: A Retrospective, Observation Study
por: Pae, Chi-Un, et al.
Publicado: (2020)

Provider Adherence to Pre-exposure Prophylaxis Monitoring Guidelines in a Large Primary Care Network
por: Spinelli, Matthew A, et al.
Publicado: (2018)

De novo variants of NR4A2 are associated with neurodevelopmental disorder and epilepsy
por: Singh, Sakshi, et al.
Publicado: (2020)

Monitoring of antipsychotic plasma levels in the assessment of poor response and nonadherence to antipsychotics in delusional disorder
por: González-Rodríguez, A., et al.
Publicado: (2021)

Incidence of Neutropenia with Valproate, Antipsychotics, and ADHD Medication Combination Treatment in Children and Adolescents
por: Oh, Yunhye, et al.
Publicado: (2020)

Comparison of Laboratory Data between Children with Kawasaki Disease and COVID-19
por: Liu, Xiao-Ping, et al.
Publicado: (2022)

Inhibition of Epstein-Barr Virus Lytic Reactivation by the Atypical Antipsychotic Drug Clozapine
por: Anderson, Abbie G., et al.
Publicado: (2019)

Applicability of somatic monitoring instructions in clinical practice guidelines on antipsychotic drug use
por: Brouwer, Jurriaan M. J. L., et al.
Publicado: (2021)

Physical health in children with neurodevelopmental disorders
por: Alabaf, Setareh, et al.
Publicado: (2018)

Non-Invasive Optical Sensor Based Approaches for Monitoring Virus Culture to Minimize BSL3 Laboratory Entry
por: Ragupathy, Viswanath, et al.
Publicado: (2015)

Corynebacterium kroppenstedtii Is an Emerging Cause of Mastitis Especially in Patients With Psychiatric Illness on Antipsychotic Medication
por: Wong, Sally C. Y., et al.
Publicado: (2017)

Impact of the Olig Family on Neurodevelopmental Disorders
por: Szu, Jenny, et al.
Publicado: (2021)

Clinical impact of splicing in neurodevelopmental disorders
por: Sanders, Stephan J., et al.
Publicado: (2020)

Investigating the impact of the environment on neurodevelopmental disorder
por: Volk, Heather, et al.
Publicado: (2020)

Pubertal stage, sex and behaviour in neurodevelopmental disorders versus typical development: a cross-sectional study
por: Penner, Melanie, et al.
Publicado: (2022)

Deficiency of the Cyclin-Dependent Kinase Inhibitor, CDKN1B, Results in Overgrowth and Neurodevelopmental Delay
por: Grey, William, et al.
Publicado: (2013)

Positive Symptoms in Antipsychotic-naïve Schizophrenia are Associated with Increased Body Mass Index after Treatment
por: Lin, Shih-Hsien, et al.
Publicado: (2021)

The in Vitro Actions of Loxapine on Dopaminergic and Serotonergic Receptors. Time to Consider Atypical Classification of This Antipsychotic Drug?
por: Ferreri, Florian, et al.
Publicado: (2017)

The Cumulative Effect of Antipsychotic Usage on Mortality in Schizophrenia: A Nationwide Population-based Cohort Study in Korea
por: Kim, Gyurin, et al.
Publicado: (2022)

Future Challenges in Research in Children with Neurodevelopmental Disorders
por: Romero-Ayuso, Dulce
Publicado: (2021)

Participation in Physical Activity for Children with Neurodevelopmental Disorders
por: Arim, Rubab G., et al.
Publicado: (2012)

Correction to: Physical health in children with neurodevelopmental disorders
por: Alabaf, Setareh, et al.
Publicado: (2018)

Verbal Fluency Test in Children with Neurodevelopmental Disorders
por: Vaucheret Paz, Esteban, et al.
Publicado: (2020)

The role of cannabinoids in neurodevelopmental disorders of children and adolescents
por: de Freitas, Francisca Dias, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kavkhviishb2hjp6dtegm7389b